FDA updates guidance on coronavirus tests

By LabPulse.com staff writers

May 15, 2020 -- The U.S. Food and Drug Administration (FDA) has released an updated guidance document on coronavirus testing for clinical laboratories and commercial manufacturers reflecting the fast-moving pandemic landscape.

The guidance document sets policy for test standards on an emergency basis; it takes effect immediately, though the agency is accepting comments from stakeholders. Guidance on the agency's policies for COVID-19 testing was initially published on February 29 and has now been revised three times.

The document sets out policies for accelerating development of lab tests through two different pathways, one of which entails an emergency use authorization (EUA) and the other of which does not. It also addresses specimen testing by labs for validation of commercial tests and policy on serology testing. Furthermore, the agency has provided templates for submissions of EUAs for three types of testing -- molecular, antigen, and serology -- in a bid to speed up the process.

FDA-authorized antibody tests fall short in comparative study
Commercial serology tests from PerkinElmer subsidiary Euroimmun and Abbott fell short of expectations in a comparative study of specimens, underscoring...
FDA alert leaves Abbott's ID Now rapid coronavirus test down -- but not out
The U.S. Food and Drug Administration (FDA) is working with Abbott Diagnostics to address reports of false negatives from the company's ID Now rapid point-of-care...
APHL offers guidance on assessing coronavirus antibody tests
Guidance on assessing the value of antibody tests for the novel coronavirus was jointly released by the Association of Public Health Laboratories (APHL)...
FDA policy change may put an end to 'Wild West' of coronavirus antibody tests
The U.S. Food and Drug Administration (FDA) is cracking down on requirements for commercial manufacturers of antibody tests for the novel coronavirus,...
FDA lets labs move ahead on in-house coronavirus tests
In a move that underscores the seriousness of the coronavirus outbreak, the U.S. Food and Drug Administration (FDA) on February 29 issued guidance to...

Copyright © 2020 LabPulse.com

Last Updated ls 5/15/2020 3:12:31 PM